Alzheon Appoints Pauly as Head of Commercial
In full transparency, the following press release & photo were submitted to SOURCE media through its business wire service. ***
Read more
Alzheon
Peer-Reviewed Scientific Publication Demonstrates Central Role of Neurotoxic Soluble Amyloid Oligomers in Driving Alzheimer’s Pathogenesis
In full transparency, the following was submitted to SOURCE media via its business wire service. *** FRAMINGHAM – Alzheon, Inc.,
Read more
Alzheon Announces First Patient in Phase 3 Trial of Oral ALZ‑801 For Those Battling Early Alzheimer’s Disease
In full transparency, the following is a media release submitted to SOURCE via its business wire service. *** FRAMINGHAM –
Read more
Alzheon Partners With Czech Institute of Organic Chemistry & Biochemistry To Develop Alzheimer’s Diagnostic Test
In full transparency, the following is a press release submitted to SOURCE media through its business wire service. *** FRAMINGHAM
Read more
Alzheon Announces Study to Evaluate ALZ-801 Effects on Alzheimer’s Biomarkers
The following is a press release submitted to SOURCE from its business wire service. *** FRAMINGHAM- Alzheon, Inc., a clinical-stage
Read more
Framingham Company Awarded $47 Million Grant For Alzheimer’s Treatment
The following is a press release *** FRAMINGHAM – Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines
Read more